Travelers Vaccines Market Geographic Segmentation, Analysis by Types and Regions and Forecast to 2022
© Satish Inamdar
Global Travelers Vaccines Market is segmented on the basis of product types, application and geography. The agent stimulates the immune system of the body for identifying the agent as foreign, destroying it, and “remembering” it, so that the immune system could easily recognize and destroy any of these microorganisms that it later encounters is termed as a vaccine.
Access Travelers Vaccines Market Report with TOC @ https://www.millioninsights.com/industry-reports/travellers-vaccines-market
The introduction of additional age group coverage is one of the primary factors driving the travelers vaccines market’s growth. While approving a vaccine, the regulatory authorities also specify the age group approved for receiving the vaccine. This age group is particular on the vaccine label and is based on the efficacy and safety results obtained from clinical trials conducted using individuals from these age groups. Label expansion to include additional age groups approved for immunization requires additional regulatory approval.
These approvals are based on the additional clinical trials conducted using individuals from additional age groups. The increase in approvals for additional age group coverage will increase the patient population for the vaccine, thereby propelling the travelers vaccines market’s growth in the coming years. Based on product types, the travelers vaccines market is classified as japanese encephalitis vaccine, meningococcal vaccine, rabies vaccine, yellow fever vaccine, typhoid vaccine, hepatitis B vaccine, hepatitis A vaccine, cholera vaccine, combination vaccine and mono vaccine.
The segment “combination vaccines” is one of the fastest rising segments of the travelers vaccines market. These vaccines present protection against different causative agents for diseases such as meningitis, measles, rubella, mumps, diphtheria, pertussis and tetanus. Menhibrix and Menitronix are the most commonly used combination vaccines. While Menhibrix is approved for the prevention of invasive disease caused by Haemophilus influenza type b and N, meningitidis serogroups C and Y. Menitronix is approved for the prevention of invasive diseases caused by N. meningitidis serogroup C and H. influenza type b. Moreover, combination vaccines ensure better patient compliance, which will also contribute to this segment’s growth in the coming years. Based on application, the travelers vaccines market is classified as tourists, students, workers and so on.
Top Key Players Analysis covered in Travelers Vaccines Market Report
• GlaxoSmithKline/Novartis
• Sanofi Pasteur
• Pfizer
• Merck
• Sanofi Pasteur MSD
• CNBG
• Biokangtai
Segmentation on the basis of Product Types,
• Meningococcal Vaccine
• Japanese Encephalitis Vaccine
• Rabies Vaccine
• Typhoid Vaccine
• Yellow Fever Vaccine
• Hepatitis B Vaccine
• Hepatitis A Vaccine
• Cholera Vaccine
• Others Vaccines (Hepatitis E Vaccines, Tick-Borne Encephalitis Vaccine, etc.)
Segmentation on the basis of Applications/End-Users,
• Tourists
• Students
• Workers
• Others
Request a Sample Copy of Travelers Vaccines Market Report @
https://www.millioninsights.com/industry-reports/travellers-vaccines-market/request-sample
Based on geography, the travelers vaccines market is classified as Middle East & Africa, Latin America, Europe, Asia Pacific and North America. The North America was the highest profits contributing region in the market during 2015 and will continue to lead the market in the coming years. The U.S. was one of the highest revenue contributors in the region, capturing a significant portion of the market. The increasing demand for vaccines that provide to the unmet medical needs provides an opportunity for vendors to develop new safe and efficient molecules, which will assist in the growth of the travelers vaccines market in the region.
Visit Our Blog @ https://marketfuturereports.wordpress.com
Get in touch
At Million Insights, we work with the aim to reach the highest levels of customer satisfaction. Our representatives strive to understand diverse client requirements and cater to the same with the most innovative and functional solutions.
Contact Person:
Ryan Manuel
Research Support Specialist, USA
Email: ryan@millioninsights.com
Million Insights
Office No. 302, 3rd Floor, Manikchand Galleria,
Model Colony, Shivaji Nagar, Pune, MH, 411016 India
Phone: 91-20-65300184
Email: sales@millioninsights.com
Access Travelers Vaccines Market Report with TOC @ https://www.millioninsights.com/industry-reports/travellers-vaccines-market
The introduction of additional age group coverage is one of the primary factors driving the travelers vaccines market’s growth. While approving a vaccine, the regulatory authorities also specify the age group approved for receiving the vaccine. This age group is particular on the vaccine label and is based on the efficacy and safety results obtained from clinical trials conducted using individuals from these age groups. Label expansion to include additional age groups approved for immunization requires additional regulatory approval.
These approvals are based on the additional clinical trials conducted using individuals from additional age groups. The increase in approvals for additional age group coverage will increase the patient population for the vaccine, thereby propelling the travelers vaccines market’s growth in the coming years. Based on product types, the travelers vaccines market is classified as japanese encephalitis vaccine, meningococcal vaccine, rabies vaccine, yellow fever vaccine, typhoid vaccine, hepatitis B vaccine, hepatitis A vaccine, cholera vaccine, combination vaccine and mono vaccine.
The segment “combination vaccines” is one of the fastest rising segments of the travelers vaccines market. These vaccines present protection against different causative agents for diseases such as meningitis, measles, rubella, mumps, diphtheria, pertussis and tetanus. Menhibrix and Menitronix are the most commonly used combination vaccines. While Menhibrix is approved for the prevention of invasive disease caused by Haemophilus influenza type b and N, meningitidis serogroups C and Y. Menitronix is approved for the prevention of invasive diseases caused by N. meningitidis serogroup C and H. influenza type b. Moreover, combination vaccines ensure better patient compliance, which will also contribute to this segment’s growth in the coming years. Based on application, the travelers vaccines market is classified as tourists, students, workers and so on.
Top Key Players Analysis covered in Travelers Vaccines Market Report
• GlaxoSmithKline/Novartis
• Sanofi Pasteur
• Pfizer
• Merck
• Sanofi Pasteur MSD
• CNBG
• Biokangtai
Segmentation on the basis of Product Types,
• Meningococcal Vaccine
• Japanese Encephalitis Vaccine
• Rabies Vaccine
• Typhoid Vaccine
• Yellow Fever Vaccine
• Hepatitis B Vaccine
• Hepatitis A Vaccine
• Cholera Vaccine
• Others Vaccines (Hepatitis E Vaccines, Tick-Borne Encephalitis Vaccine, etc.)
Segmentation on the basis of Applications/End-Users,
• Tourists
• Students
• Workers
• Others
Request a Sample Copy of Travelers Vaccines Market Report @
https://www.millioninsights.com/industry-reports/travellers-vaccines-market/request-sample
Based on geography, the travelers vaccines market is classified as Middle East & Africa, Latin America, Europe, Asia Pacific and North America. The North America was the highest profits contributing region in the market during 2015 and will continue to lead the market in the coming years. The U.S. was one of the highest revenue contributors in the region, capturing a significant portion of the market. The increasing demand for vaccines that provide to the unmet medical needs provides an opportunity for vendors to develop new safe and efficient molecules, which will assist in the growth of the travelers vaccines market in the region.
Visit Our Blog @ https://marketfuturereports.wordpress.com
Get in touch
At Million Insights, we work with the aim to reach the highest levels of customer satisfaction. Our representatives strive to understand diverse client requirements and cater to the same with the most innovative and functional solutions.
Contact Person:
Ryan Manuel
Research Support Specialist, USA
Email: ryan@millioninsights.com
Million Insights
Office No. 302, 3rd Floor, Manikchand Galleria,
Model Colony, Shivaji Nagar, Pune, MH, 411016 India
Phone: 91-20-65300184
Email: sales@millioninsights.com